SUBJID,TREATMENT,AESEQ,AESOC,AEDECOD,AETERM,AESEV,AESER,AESTDY,AEENDY
01-701-1015,Placebo,1,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MILD,N,2,
01-701-1015,Placebo,2,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MILD,N,2,
01-701-1015,Placebo,3,GASTROINTESTINAL DISORDERS,DIARRHOEA,DIARRHOEA,MILD,N,8,10
01-701-1023,Placebo,2,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MODERATE,N,3,
01-701-1023,Placebo,1,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MILD,N,3,26
01-701-1023,Placebo,4,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MILD,N,3,26
01-701-1023,Placebo,3,CARDIAC DISORDERS,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,MILD,N,22,
01-701-1028,Xanomeline High Dose,1,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MILD,N,3,
01-701-1028,Xanomeline High Dose,2,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MILD,N,21,
01-701-1034,Xanomeline High Dose,1,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MILD,N,58,
01-701-1034,Xanomeline High Dose,2,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,FATIGUE,MILD,N,125,
01-701-1047,Placebo,1,GASTROINTESTINAL DISORDERS,HIATUS HERNIA,HIATUS HERNIA,MODERATE,N,1,1
01-701-1047,Placebo,2,GASTROINTESTINAL DISORDERS,HIATUS HERNIA,HIATUS HERNIA,MODERATE,N,1,1
01-701-1047,Placebo,3,INFECTIONS AND INFESTATIONS,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,MILD,N,23,
01-701-1047,Placebo,4,CARDIAC DISORDERS,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,MILD,N,27,
01-701-1097,Xanomeline Low Dose,2,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS GENERALISED,PRURITUS GENERALISED,MODERATE,N,51,51
01-701-1097,Xanomeline Low Dose,10,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MODERATE,N,52,
01-701-1097,Xanomeline Low Dose,5,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS GENERALISED,PRURITUS GENERALISED,MODERATE,N,80,80
01-701-1097,Xanomeline Low Dose,6,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS GENERALISED,PRURITUS GENERALISED,MODERATE,N,90,90
01-701-1097,Xanomeline Low Dose,7,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS GENERALISED,PRURITUS GENERALISED,MODERATE,N,109,110
01-701-1097,Xanomeline Low Dose,1,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MILD,N,3,
01-701-1097,Xanomeline Low Dose,3,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,MILD,N,51,53
01-701-1097,Xanomeline Low Dose,4,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MILD,N,52,
01-701-1097,Xanomeline Low Dose,8,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,MILD,N,109,112
01-701-1097,Xanomeline Low Dose,9,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,NASAL CONGESTION,MILD,N,109,112
01-701-1111,Xanomeline Low Dose,7,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRALGIA,ARTHRALGIA,MODERATE,N,7,
01-701-1111,Xanomeline Low Dose,8,INFECTIONS AND INFESTATIONS,CELLULITIS,CELLULITIS,MODERATE,N,7,
01-701-1111,Xanomeline Low Dose,6,RENAL AND URINARY DISORDERS,MICTURITION URGENCY,MICTURITION URGENCY,MILD,N,1,
01-701-1115,Xanomeline Low Dose,5,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MODERATE,N,3,
01-701-1115,Xanomeline Low Dose,6,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MODERATE,N,3,
01-701-1115,Xanomeline Low Dose,7,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,FATIGUE,MODERATE,N,46,
01-701-1115,Xanomeline Low Dose,8,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,MODERATE,N,51,
01-701-1115,Xanomeline Low Dose,9,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,MODERATE,N,51,
01-701-1115,Xanomeline Low Dose,1,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MILD,N,3,
01-701-1115,Xanomeline Low Dose,2,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MILD,N,3,
01-701-1115,Xanomeline Low Dose,3,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,MILD,N,27,27
01-701-1115,Xanomeline Low Dose,4,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,MILD,N,27,27
01-701-1130,Placebo,1,INFECTIONS AND INFESTATIONS,URINARY TRACT INFECTION,URINARY TRACT INFECTION,MILD,N,23,30
01-701-1130,Placebo,2,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PYREXIA,PYREXIA,MILD,N,23,23
01-701-1130,Placebo,3,INFECTIONS AND INFESTATIONS,URINARY TRACT INFECTION,URINARY TRACT INFECTION,MILD,N,23,30
01-701-1130,Placebo,4,EYE DISORDERS,EYE SWELLING,EYE SWELLING,MILD,N,84,84
01-701-1130,Placebo,5,EYE DISORDERS,EYE ALLERGY,EYE ALLERGY,MILD,N,84,84
01-701-1130,Placebo,6,EYE DISORDERS,EYE PRURITUS,EYE PRURITUS,MILD,N,97,
01-701-1130,Placebo,7,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,PRURITUS,MILD,N,97,
01-701-1130,Placebo,8,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,NASAL CONGESTION,MILD,N,97,
01-701-1133,Xanomeline High Dose,3,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MODERATE,N,61,
01-701-1133,Xanomeline High Dose,4,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MODERATE,N,61,
01-701-1133,Xanomeline High Dose,1,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MILD,N,61,
01-701-1133,Xanomeline High Dose,2,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MILD,N,61,
01-701-1146,Xanomeline High Dose,7,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MODERATE,N,22,
01-701-1146,Xanomeline High Dose,8,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MODERATE,N,22,
01-701-1146,Xanomeline High Dose,9,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PAIN,APPLICATION SITE PAIN,MODERATE,N,34,
01-701-1146,Xanomeline High Dose,10,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,MODERATE,N,38,
01-701-1146,Xanomeline High Dose,11,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,MODERATE,N,38,
01-701-1146,Xanomeline High Dose,3,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,MILD,N,13,14
01-701-1146,Xanomeline High Dose,4,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,FATIGUE,MILD,N,15,
01-701-1146,Xanomeline High Dose,5,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MILD,N,22,
01-701-1146,Xanomeline High Dose,6,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MILD,N,22,
01-701-1148,Xanomeline High Dose,3,INFECTIONS AND INFESTATIONS,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,MODERATE,N,51,80
01-701-1148,Xanomeline High Dose,4,INFECTIONS AND INFESTATIONS,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,MODERATE,N,51,80
01-701-1148,Xanomeline High Dose,5,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,FLANK PAIN,FLANK PAIN,MODERATE,N,115,117
01-701-1148,Xanomeline High Dose,6,RENAL AND URINARY DISORDERS,CALCULUS URETHRAL,CALCULUS URETHRAL,MODERATE,N,117,117
01-701-1148,Xanomeline High Dose,1,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MILD,N,3,
01-701-1148,Xanomeline High Dose,2,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MILD,N,3,
01-701-1148,Xanomeline High Dose,7,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",EPISTAXIS,EPISTAXIS,MILD,N,134,134
01-701-1148,Xanomeline High Dose,10,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ACTINIC KERATOSIS,ACTINIC KERATOSIS,MILD,N,174,
01-701-1153,Placebo,1,METABOLISM AND NUTRITION DISORDERS,INCREASED APPETITE,INCREASED APPETITE,MILD,N,21,45
01-701-1153,Placebo,2,METABOLISM AND NUTRITION DISORDERS,INCREASED APPETITE,INCREASED APPETITE,MILD,N,21,45
01-701-1180,Xanomeline High Dose,7,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,MODERATE,N,36,
01-701-1180,Xanomeline High Dose,8,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MODERATE,N,36,
01-701-1180,Xanomeline High Dose,9,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MODERATE,N,36,
01-701-1180,Xanomeline High Dose,1,GASTROINTESTINAL DISORDERS,VOMITING,VOMITING,MILD,N,1,1
01-701-1180,Xanomeline High Dose,2,GASTROINTESTINAL DISORDERS,VOMITING,VOMITING,MILD,N,1,1
01-701-1180,Xanomeline High Dose,3,RENAL AND URINARY DISORDERS,MICTURITION URGENCY,MICTURITION URGENCY,MILD,N,4,36
01-701-1180,Xanomeline High Dose,6,RENAL AND URINARY DISORDERS,MICTURITION URGENCY,MICTURITION URGENCY,MILD,N,4,36
01-701-1180,Xanomeline High Dose,5,INFECTIONS AND INFESTATIONS,NASOPHARYNGITIS,NASOPHARYNGITIS,MILD,N,23,24
01-701-1181,Xanomeline High Dose,1,PSYCHIATRIC DISORDERS,AGITATION,AGITATION,MODERATE,N,5,5
01-701-1188,Xanomeline Low Dose,3,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MODERATE,N,2,
01-701-1188,Xanomeline Low Dose,4,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,PRURITUS,MODERATE,N,2,
01-701-1188,Xanomeline Low Dose,6,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,URTICARIA,URTICARIA,MODERATE,N,18,
01-701-1188,Xanomeline Low Dose,1,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MILD,N,2,
01-701-1188,Xanomeline Low Dose,2,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,PRURITUS,MILD,N,2,
01-701-1188,Xanomeline Low Dose,5,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,URTICARIA,URTICARIA,MILD,N,18,
01-701-1188,Xanomeline Low Dose,7,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,MILD,N,35,
01-701-1188,Xanomeline Low Dose,8,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,URTICARIA,URTICARIA,MILD,N,35,
01-701-1192,Xanomeline Low Dose,7,INFECTIONS AND INFESTATIONS,PNEUMONIA,PNEUMONIA,MODERATE,N,48,77
01-701-1192,Xanomeline Low Dose,8,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MODERATE,N,48,71
01-701-1192,Xanomeline Low Dose,10,INFECTIONS AND INFESTATIONS,PNEUMONIA,PNEUMONIA,MODERATE,N,48,77
01-701-1192,Xanomeline Low Dose,11,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MODERATE,N,48,71
01-701-1192,Xanomeline Low Dose,1,INVESTIGATIONS,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,MILD,N,13,13
01-701-1192,Xanomeline Low Dose,2,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SECRETION DISCHARGE,SECRETION DISCHARGE,MILD,N,17,55
01-701-1192,Xanomeline Low Dose,3,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MILD,N,17,55
01-701-1192,Xanomeline Low Dose,5,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SECRETION DISCHARGE,SECRETION DISCHARGE,MILD,N,17,55
01-701-1192,Xanomeline Low Dose,6,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MILD,N,17,55
01-701-1192,Xanomeline Low Dose,12,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,MILD,N,137,148
01-701-1192,Xanomeline Low Dose,13,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MILD,N,137,
01-701-1192,Xanomeline Low Dose,14,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MILD,N,137,
01-701-1192,Xanomeline Low Dose,15,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,MILD,N,137,148
01-701-1203,Placebo,1,SURGICAL AND MEDICAL PROCEDURES,EYE LASER SURGERY,EYE LASER SURGERY,MILD,N,48,48
01-701-1211,Xanomeline Low Dose,9,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SUDDEN DEATH,SUDDEN DEATH,SEVERE,N,61,61
01-701-1211,Xanomeline Low Dose,2,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",JOINT DISLOCATION,JOINT DISLOCATION,MODERATE,N,7,7
01-701-1211,Xanomeline Low Dose,7,PSYCHIATRIC DISORDERS,CONFUSIONAL STATE,CONFUSIONAL STATE,MODERATE,N,58,
01-701-1211,Xanomeline Low Dose,8,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPNOEA,DYSPNOEA,MODERATE,N,58,
01-701-1211,Xanomeline Low Dose,1,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,MILD,N,2,
01-701-1211,Xanomeline Low Dose,3,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,SHOULDER PAIN,SHOULDER PAIN,MILD,N,7,
01-701-1211,Xanomeline Low Dose,4,RENAL AND URINARY DISORDERS,INCONTINENCE,INCONTINENCE,MILD,N,8,
01-701-1211,Xanomeline Low Dose,5,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,MILD,N,15,
01-701-1211,Xanomeline Low Dose,6,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SKIN LACERATION,SKIN LACERATION,MILD,N,25,
01-701-1239,Xanomeline High Dose,6,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MODERATE,N,2,
01-701-1239,Xanomeline High Dose,1,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MILD,N,2,
01-701-1239,Xanomeline High Dose,2,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,MILD,N,2,
01-701-1239,Xanomeline High Dose,3,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,PRURITUS,MILD,N,3,
01-701-1239,Xanomeline High Dose,4,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,MILD,N,10,29
01-701-1239,Xanomeline High Dose,5,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,MILD,N,10,29
01-701-1239,Xanomeline High Dose,7,INFECTIONS AND INFESTATIONS,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,MILD,N,41,61
01-701-1239,Xanomeline High Dose,8,INFECTIONS AND INFESTATIONS,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,MILD,N,41,61
01-701-1239,Xanomeline High Dose,9,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,FATIGUE,MILD,N,50,
01-701-1239,Xanomeline High Dose,10,INFECTIONS AND INFESTATIONS,HORDEOLUM,HORDEOLUM,MILD,N,81,
01-701-1275,Xanomeline High Dose,1,GASTROINTESTINAL DISORDERS,NAUSEA,NAUSEA,MILD,N,7,117
01-701-1275,Xanomeline High Dose,11,GASTROINTESTINAL DISORDERS,NAUSEA,NAUSEA,MILD,N,7,117
01-701-1275,Xanomeline High Dose,2,GASTROINTESTINAL DISORDERS,VOMITING,VOMITING,MILD,N,17,17
01-701-1275,Xanomeline High Dose,3,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MILD,N,18,126
01-701-1275,Xanomeline High Dose,4,GASTROINTESTINAL DISORDERS,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,MILD,N,18,117
01-701-1275,Xanomeline High Dose,5,NERVOUS SYSTEM DISORDERS,PAROSMIA,PAROSMIA,MILD,N,18,117
01-701-1275,Xanomeline High Dose,6,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,PRURITUS,MILD,N,18,126
01-701-1275,Xanomeline High Dose,12,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,ERYTHEMA,MILD,N,18,126
01-701-1275,Xanomeline High Dose,13,GASTROINTESTINAL DISORDERS,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,MILD,N,18,117
01-701-1275,Xanomeline High Dose,14,NERVOUS SYSTEM DISORDERS,PAROSMIA,PAROSMIA,MILD,N,18,117
01-701-1275,Xanomeline High Dose,15,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,PRURITUS,MILD,N,18,126
01-701-1275,Xanomeline High Dose,7,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",COUGH,COUGH,MILD,N,34,49
01-701-1275,Xanomeline High Dose,8,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,NASAL CONGESTION,MILD,N,34,49
01-701-1275,Xanomeline High Dose,9,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",COUGH,COUGH,MILD,N,34,49
01-701-1275,Xanomeline High Dose,10,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,NASAL CONGESTION,MILD,N,34,49
01-701-1033,Xanomeline Low Dose,,,,,,,,
01-701-1118,Placebo,,,,,,,,
01-701-1234,Placebo,,,,,,,,